Welocity Genetics : Where Genetics Meets Daily Wellness

Stan Serrao, Chairman & Managing Director

Stan Serrao

Chairman & Managing Director

The genomic wellness industry in India is still navigating a complex set of challenges. Limited public awareness, misconceptions that genetics is only about rare heredity diseases, and the belief that daily health action is needed only after symptoms arise continue to slow adoption. Most people struggle to translate early detection of their health risks into practical lifestyle changes, while relatively a longer turnaround time, perceived cost, and lack of trained genetic counsellors and professionals add to further hesitation. The gap between advanced genomic science and every day actionable wellness guidance remains a major pain point. This is especially evident in healthcare systems that prioritizes treatment over prevention.

Welocity Genetics fills these gaps by positioning  genomics as a consumer-centric preventive wellness  option as opposed to expensive clinical interventions. The  company offers health-conscious individuals to have a clear  and strong understanding of their genetic predispositions  and take appropriate action through simplified once-in a-lifetime at-home DNA testing, DNA comprehensive DNA  report, multilingual genetic counselling and year-long  wellness helpdesk assistance. Their cohesive solutions  integrate gene-based personalized nutrition, fitness  with customized exercise regimen and a wide range of  lifestyle choices including sleep patterns, mindfulness,  gratitude, healthy habits, and behavioural advisory, and  its education division develops trained professionals to  create awareness scaling.

Personalized Wellness Through Genetic Insights

Welocity Genetics is a genomic wellness company that  deals with personalized gene-based preventive health  solutions based on scientific genetic insights. The company  operates at the intersection of genomics, nutrition and  lifestyle modifications while creating mass awareness,  with the objective of helping individuals and families  understand their genetic predispositions and make  informed, proactive health choices. 

The main offering of the company is the once-in-a lifetime genetic profiling, which is provided by a simple  at-home saliva-based DNA test. Clients are provided with a comprehensive, consumer-friendly genetic wellness report  after the sample is collected and processed in a specialized  DNA laboratory. The report covers various panels, such  as nutritional deficiencies, nutrition metabolism, dietary  intolerance, fitness sensitivity, sleep habits, emotional  characteristics, addictive behaviours, comprehensive  organ health risks, and lifestyle predispositions, such  as diabetes, obesity, and cardiac vulnerability. Notably,  the company makes genetics a predictive and preventive  instrument rather than a diagnostic or medical treatment.

One of the major strengths of the company is its support  with DNA report interpretation and genetic counselling.  All valued clients are provided with a scientific counselling  session, whether online or in person, in which professional  and experienced genetic counsellors interpret the complex  genetic information into real-life actionable tips. Apart  from English and Hindi, counselling is provided in many  Indian languages, which makes it easier for different  regions and age groups. The company designs tailor-made  gene-based meal plans and daily-routine plans based on  genetic insights and existing lifestyle habits, with a high  focus on food as the key lever of long-term health.

Genetics is not about predicting disease; it is about predicting possibilities

Stan Serrao, Chairman & Managing Director

In addition to individual testing, the company has  established a robust education and capacity-building  ecosystem with its academic division - Welocity Institute  of Genomics, Nutrition and Entrepreneurship Training  (WIGNET). Through flagship programs such as 2-month  Online Certificate Course in Nutrigenomics (CCNG), the  company has trained medical doctors, AYUSH practitioners,  nutritionists, dietitians, wellness professionals and  aspiring wellness enthusiasts. These programs enable  health-conscious individuals to responsibly apply genomics  in real-world settings. This education-oriented approach  has been extremely successful in reducing the gap in  awareness and promote ethical use of genomic science as a  wellness practice.

Welocity Genomics also provides Student Genomics,  a school-going children (between 3 – 19 years) oriented  genetic testing that maps their health, nutrition, learning  style, personality characteristics, and individual talents in  children and youths in their growth years. The company  also offers 6-month support after the testing, ensuring that  it is possible to implement continuous guidance, lifestyle  tracking, and wellness optimization.

“Genetics is not about predicting disease; it is about  predicting possibilities,” says Stan Serrao, Chairman  & Managing Director of Welocity Life Sciences. “When  individuals understand their genetic blueprint early, they  gain the power to make low-cost, high-impact lifestyle  choices.” “That shift - from reaction to prevention - is the  future of healthcare.”

From Vision to Gene-Based Wellness Leadership

Welocity Genetics was founded in 2016, under the leadership  of Stan Serrao, when genomics was still a research and  clinical diagnostics field in India. The company officially  rolled out its unique services in 2017 and placed itself in  the field of consumer genomics, nutrition, and preventive  health-related wellness, which was a comparatively an  unexplored territory in the Indian consumer health sector.

Though Covid-19 dented its operational efficiency,  primarily due to challenges of handling biological samples  and economic slowdown, it withstood the test of the time  and consolidated its position thanks to the deep conviction  in the fascinating science of genetics and organizational  passion. With necessary organizational restructuring,  today, Welocity Genetics has emerged as a credible player  in the Indian genomics space and positioned itself as the  pioneer and market leaders having stepped into its 10th  year of successful operation. 

Looking ahead, Welocity Genetics is committed to  establish itself as a key player in the future of genomics in  the mainstream of preventive healthcare in India. One of  its focus areas is to continue creating mass awareness and  offer industry-specific education, whereby the company  has planned to substantially increase its academic  component with innovative courses in genomic wellness  including nutrigenomics and epigenetics. Company has  set a smart goal of certifying a large number of genomic  wellness professionals in 2026 alone, building a proficient  ecosystem that can lead to mass consumption.

At the consumer level, the company is committed to  scale-up its genetic wellness offerings throughout India and  will also plans to penetrate into a few international markets.  While Welocity Genetics is committed to maintain strategic  distinction between clinical treatment, it aims to enable  access to evidence-based advanced genetic risk screening  by collaborating with medical experts, and continue to  focus on non-medical, lifestyle-based interventions. Having  prevention, personalization, and education at its heart,  the company is also working towards a vision of genomics  being integrated as a fundamental component of day-to-day  health decisions.

on the deck


Most Viewed

Addressing Antimicrobial Resistance (AMR) Through Collaborative Efforts Fostering a Quality Culture in the Pharmaceutical Industry Advancements in Computer-Aided Drug Design for Pharmaceutical Research Why India is Gaining Popularity for Clinical Trials The Future of Kidney Transplants in India Usage of Conversational AI in the Health Insurance Sector Strategies for India to Reduce Its API Dependence on China Business Impact of USFDA Approvals on Indian Pharma Companies Innovative Strategies for Expanding Access to Life Saving Healthcare Solutions Badhal Village Crisis: How Rapid Diagnostics Could Have Saved Lives Why India is a Hotspot for Biotech Startups? Why Adapting Flexibility in IP Rights will Drive Generics Market Meeting the Challenges of High-Potency API (HPAPI) Production Impact of Human Factors Engineering on Medical Device Safety The Future of Pharma: Embracing Continuous Manufacturing The Role of Orphan Drugs in Treating Rare Diseases Emerging Technologies Shaping the Future of Drug Formulation Strategies for Optimizing Pharmaceutical Supply Chain Efficiency The Future of Medicine: Harnessing the Power of RNA-based Therapeutics AI in Medicine: Unmasking the Myths and Embracing the Transformative Reality Cycle Pharma Acquires Banner Life Sciences WHO's First-ever Global Summit on Traditional Medicine Starts in Gujarat The Importance of Data Integrity in Pharmaceutical Quality Control DCGI in Talks with Stakeholders to Develop a Standardised Web Platform to Assure Drug Quality and Patient Safety Glenmark Pharmaceuticals secures ANDA Nod for 0.03 per cent Tacrolimus Ointment Streamlining Laboratory Operations with a Modern LIMS Healthtech Start-up Suraksha QR Ropes In Actor Murali Sharma as its Brand Ambassador Unlocking the Potential of Pharmacogenomics: Enhancing Drug Safety and Efficacy The Impact of Pharmaceutical Testing on Drug Development India has Identified Three Health Priorities to Strengthen Global Health Infrastructure, says WHO National Health Authority launches 100 Microsites Project to Speed Up Digital Health Adoption India Should Partner with Australia to avail PBS for the Selection, Listing, and Pricing processes of exported drugs, says Sudarshan Jain Zydus Lifesciences India More than Doubles Profit Due to Increased Sales in the US India Triples Organ Donations over Past Decade says Union health minister Mansukh Mandaviya Advent Therapeutics Awarded $3 Million NIH Grant For Novel Neonatal Lung Therapy Three Pharma Marketing Strategies That Drive Sales Novartis Targets India's Rare Disease Market with 17 Clinical Programs UK Health Regulator approves GSK's Vaccine for the common respiratory virus RSV WHO Urges Increased Use Of Recommended Malaria-Fighting Tools Karnataka Budget Offered a Significant Boost to Health & Lifesciences Start-ups with Focus on Infrastructure & Innovation Three High Potential Moonshot Project Areas in Pharma CCI approves Bharat Biotech International-Eastman Exports deal How Biotech is Revolutionizing the Fight Against Cancer LifeCell and HaystackAnalytics ink strategic pact to scale-up TB whole genome sequencing pan-India Mankind Pharma IPO To Open On April 25 With A Price Fixed At Rs 1,026-1,080 Per Share US CDC Approves Second Omicron-Updated COVID Booster For Adults Three Trends that will Impact Pharmaceutical Industry in 2023 ModeX Therapeutics Commences Phase I EBV Vaccine Trial with Merck Designing Impactful Leadership and Talent Management Programs with Strategies for Success Novo Nordisk and Valo Health Partner to develop novel Treatments FOPE Calls for Extended Deadline for Schedule M Compliance Telix Pharma To Acquire ImaginAb to Boost Therapeutics and Innovation Roche Secures US FDA Approval for its Ultra-Sensitive ISH test Rappta Therapeutics and SpringWorks Partner on Molecular Glue Targeting PP2A Taro Pharma To Acquire entire stake in Antibe Therapeutics Innovent Biologics Secures Breakthrough Therapy Designation for IBI343 Emcure Pharma Launches Largest R&D Centre in Ahmedabad Zydus Bags USFDA Nod for Phase II(b) Trial to Optimize Usnoflast Dosage US FDA Approves Amgen's Lumakras-Vectibix Combo for KRAS G12C-Mutated mCRC Glenmark Pharma Unveils generic anticoagulant injectable emulsion Strides Pharma Bags USFDA Nod for OTC Acetaminophen-Ibuprofen Combo Tablets US FDA Lifts Hold on Sanofi's Trial to Make Cialis Available Over-the-Counter Hoth Therapeutics Expands Intellectual Property with New Patents Jaguar Health Starts POC Trial of Crofelemer for Rare Pediatric Disease MVID Pharma and Healthcare Sector Eyes Union Budget 2025 for Innovation Boost How Innovative Drug Formulations are Enhancing Treatment Outcomes Apollo and Mayapada Healthcare Unite to Boost Indonesia's Healthcare Novo Nordisk Reports Positive Phase 1b/2a Results for Amycretin Govt to Extend Schedule M Compliance Deadline for Drug Manufacturers to Dec Lupin Secures US FDA Nod for Ipratropium Bromide Nasal Solution ANDA Granules Pharmaceuticals Secures USFDA Nod for Key Generic Drug Bajaj Healthcare Bags DCGI Nod to Manufacture Pimavanserin API & Formulation Union Budget 2025: Healthcare Gets 9.78% Boost, Allocation Nears 1 Lakh Crore Metropolis & Roche Launch Self-Sampling HPV Test for Cervical Cancer Sigachi Industries Invests $1M in Hyderabad R&D Hub for API Innovation Pharma Testing Market Surges with Rising Demand for Biologics ISTH Releases Clinical Practice Guideline For Haemophilia Treatment Sanofi and Biovac Lead Polio Vaccine Manufacturing Capabilities Sun Pharma and Takeda Ink Pact To Market Gastrointestinal Drug Takeda and Ascentage Pharma Ink Option Agreement For Olverembatinib Enhancing Compliance through Effective Pharmaceutical Regulatory Affairs Strategies India poised to become a Global Hub for Clinical Trials: Exec SCHOTT Pharma Unveils Next-Gen Polymer Syringes for Enhanced Safety GSK's Jemperli Gains EU Nod for First-Line Treatment of Endometrial Cancer Union Health Secretary Urges Stronger Drug Regulations for Quality Control Telangana Govt Inks Landmark Deals to Propel Life Sciences and Job Growth R&D in Indian Pharma: Breakthroughs and Innovations in 2024 Dr. Reddy's Partners with Shanghai Henlius to Develop Cancer Drug Uniphar Expands Global Footprint with Three New Facilities 74th Indian Pharmaceutical Congress 2025 Opens Registrations AGC Pharma Expands HPAPI Capabilities in Barcelona to Meet Growing Demand The Future of Genomic Sequencing: Trends That Will Define the Next Decade Lexaria Bioscience Ethics Review Board Nod to Commence New GLP-1 Study Amitabh Kant Urges India to Focus on Innovation at BioAsia 2025 Government Enhances Research & Integration Initiatives in Unani Medicine Blind & Deaf individuals face Major Barriers to access Medicines: Report C-CAMP and PariSante Campus launched Indo-French Life Sciences Hub Jaguar Health Begins Pediatric Trial for Crofelemer in Short Bowel Syndrome Algiax Pharma Reports Promising Phase 2a Results for AP-325 Govt Bans 34 Antimicrobials for Use in Animals Pharmaceutical Procurement Strategies: How to Optimize Costs Personalized Medicine: Get Tailored Treatment Plans for You Now How to Bridge the Healthcare Gap in Emerging Markets with MedTech The Evolution of In-Vitro Diagnostics: Trends and Future Prospects Needle-Free Injection System: A Game Changer in Less Pain Vaccination How Global Capability Centers are Shaping the Future of Biometrics Building a Successful Pharma Brand in India: The Role of Scientific Communication Unlocking India's Innovation Potential in Pharma The Future of Green Chemistry in API Production Top 10 Pharmaceutical Recruitment Consultants - 2024 | Pharma Outlook Blockchain for Secure Pharmaceutical Supply Chains - 2025 & Beyond Mass Spectrometry in Biomarker Discovery for Early Disease Detection Iconovo and Lonza Team up to Advance Intranasal Biologic with ICOone Nasal Fetal Imaging to Cardiac Diagnosis: The Expanding Role of Ultrasound Balancing Innovation and Affordability in Medical Solutions for India Changing Landscape for LTBI and Syndromic Testing Methodologies How Advanced Training Methods can Enhance Patient Care Balancing Cost Efficiency and Compliance in Pharmaceutical Manufacturing LUB Urges Govt to Scrap Mandatory Lab Testing for Cough Syrup Exports Role of Optical Imaging in Early Cancer Detection and Treatment Hoth Therapeutics Unveils Promising Data for KIT-Targeting Therapy Pharmexcil Engages ASEAN Nations to Boost Pharma Trade Ties Fortis Partners with Teleflex for South Asia UroLift Training Anti-Infectives: How New Research is Shaping Infection Control Building Bridges for Sustainable Growth through Strategic Alliances in Ethical Pharmaceuticals Quality as the Cornerstone of Lab Solutions FDA Approves Roch's NSCLC Diagnostic Linked to Emrelis How Early Detection is Transforming Cancer Treatment in India Ensuring Data Privacy in Pharma World Enhancing Clinical Trial Supply Chain Resilience to Address Global Disruptions in India Cost-Effectiveness of Minimally Invasive Surgery in Outpatient Settings How Organic Synthesis is Accelerating Drug Discovery in Pharma Strategic finance for pharmaceutical innovation and stability Top 10 Teleradiology Service Providers - 2024 | Pharma Outlook Importance of Investing in R&D and Quality for Competitive Advantage in Eye Care Top 10 In Vitro Diagnostics Companies - 2024 | Pharma Outlook Phytopharmaceuticals: Driving Global Herbal Medicine Innovation Gender Gap in Healthcare: Why Women's Health Needs More Research Impact of Modern Technology on the Indian Life Sciences Sector Why Global Pharma Expects CDMOs to Be Ready for Joint Inspections The Role of Customizable Stent Grafts for Treating Complex Anatomies Nutraceuticals vs Pharmaceuticals: Complementary or Alternative in Chronic Disease Management? Top 10 Pharma CDMO Companies In India – 2023 | Pharma Outlook Leaping Towards Global Compliance with Revised Schedule M Meril Concludes TechVentory, Boosts AI-Driven Healthcare Supply Chains 10 Pharma Sector Revolutions in India Standardizing Medicine Labeling and Embracing Digital Transformation Creating a patient-centric healthcare ecosystem for all Biomanufacturing of Enzymes: A Sustainable Approach to Industrial Biotechnology Integrating CSR into HR Practices to Enhance Brand Reputation in Pharma Merck Launches Phase 3 Trial for Promising Dengue Vaccine V181 Breakthrough: Eye-Opening Healthcare Strategies Doctors Swear By on Doctor's Day 2025 Bristol Myers Squibb Reports Strong Phase 3 Results for Deucravacitinib trail Alcon Launches Innovative Daily Lenses Designed for Long-lasting Comfort Apisolex Excipient by Lubrizol Backs Phase I Drug Success FDA Approves Enflonsia to Prevent RSV in Infants with One Dose Biosimilars in India 2025 Market Trends, Growth Forecast & Opportunities How Regulations Are Shaping India's Medical Device Landscape Bharat Biotech Partners with GSK for Shigella Vaccine Development Eli Lilly Obesity Drug Shows 11.5% Weight Loss in 12 Weeks Laborate Pharmaceuticals: Illuminating Pathways Of Quality, Affordability Innovation In Healthcare Sun Pharma Bags CDSCO Approval to Produce Fexuprazan Hydrochloride Tablets The Fusion of Biology, Medicine, Health, and AI Glenmark Gets DCGI Nod to Launch Oncology Drug BRUKINSA in India Kyndryl Partners with Dr Reddys to Automate Global IT Operations How Robotic Assisted Surgery Is Redefining Precision in Kidney Transplants Top 10 Women Disruptors in Asia Pharmaceutical Industry

Editor's Guest


© 2026 India Pharma Outlook. All Rights Reserved.